Skip to main content
. Author manuscript; available in PMC: 2024 Nov 1.
Published in final edited form as: Am J Obstet Gynecol MFM. 2023 Sep 30;5(11):101173. doi: 10.1016/j.ajogmf.2023.101173

Table 1.

Demographic, parent-infant dyad health and OUD treatment related variables for study sample of postpartum Medicaid members, by HOI tercile group representing neighborhood-level SDoH.*

Full sample Lowest HOI tercile Middle HOI tercile Highest HOI tercile Chi-square test

n=1690 n=711 n=647 n=332
Individual-level demographic variables
Age
 24 years or less 14.3 14.8 13.8 14.2 5.7
 25–34 years 72.4 71.2 75.1 69.9 p=0.22
 35 years or more 13.3 14.1 11.1 16.0
Race/ethnicity
 Non-Hispanic White 89.0 84.3 92.8 53.0
 Non-Hispanic Black 8.7 14.4 5.0 3.9 P<0.001
 Other 2.3 1.4 2.8 3.3
Residence type
 Urban 701 60.5 70.9 89.2 89.2
 Rural 299 39.5 29.1 10.8 P<0.001
Parent-infant dyad and health-related variables
Comorbid mental health
disorder
 Yes 62.9 63.6 60.6 66.0 3.0
 No 37.1 36.4 39.4 34.0 p=0.23
Comorbid substance use
disorder
 Yes 81.7 82.7 80.2 82.2 1.5
 No 18.3 17.3 19.8 17.8 p=0.48
Three or more emergency
department visits (prior year)
 Yes 29.9 30.0 29.7 30.4 0.1
 No 70.1 70.0 70.3 69.6 p=0.97
Overdose event (prior year)
 Yes 1.5 1.3 1.6 1.8 0.5
 No 98.5 98.7 98.5 98.2 p=0.78
Delivery type
 Cesarean 38.1 37.0 38.9 1.0
 Vaginal 56.0 56.7 55.6 55.4 p=0.91
 Undetermined 5.9 6.3 5.4 5.7
Preterm delivery
 Yes 17.8 19.3 17.5 15.1 2.8
 No 82.3 80.7 82.5 84.9
Infant diagnosis of neonatal p=0.25
abstinence syndrome
 Yes 68.9 68.5 68.2 71.1 1.0
 No 31.1 31.5 31.8 28.9 p=0.62
OUD treatment delivery variables
Prenatal MOUD duration
 None 2.9 2.5 3.3 3.0 4.9
 1 month or less 9.8 9.7 11.0 7.8 p=0.77
 1–4 months 26.7 27.7 25.0 27.7
 5–8 months 32.0 32.8 31.4 31.6
 9–12 months 28.6 27.3 29.4 29.8
OUD treatment
comprehensiveness index
 0 13.6 11.8 15.5 13.6 9.1
 1 9.0 8.6 10.4 7.2 p=0.33
 2 13.8 13.2 14.4 13.9
 3 17.5 18.0 16.1 19.0
 4+ 46.2 48.4 43.7 46.4
*

p values < 0.05 denote significance